Covestor LTD Aclaris Therapeutics, Inc. Transaction History

Covestor LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$1.01 - $1.36 $1 - $1	-1 Reduced 1.59%	62 $0
Q1 2024 May 10, 2024	BUY	$0.92 - $1.44 $45 - $70	49 Added 350.0%	63 $0
Q4 2023 Feb 09, 2024	BUY	$0.64 - $6.49 $4 - $45	7 Added 100.0%	14 $0
Q3 2023 Nov 13, 2023	SELL	$6.56 - $10.95 $6 - $10	-1 Reduced 12.5%	7 $0
Q4 2022 Feb 13, 2023	SELL	$14.33 - $18.37 $57 - $73	-4 Reduced 33.33%	8 $0
Q3 2022 Nov 14, 2022	SELL	$13.07 - $18.22 $26 - $36	-2 Reduced 14.29%	12 $0
Q2 2022 Aug 10, 2022	BUY	$10.16 - $17.08 $142 - $239	14 New	14 $0

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $137M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

Stay updated on Covestor LTD with notifications on news.